Actavis recalls diabetes drugs made by Durham-based Patheon
Actavis, the generic drug unit that Allergan (NYSE: AGN) recently sold to Teva Pharmaceutical Industries (NYSE: TEVA), has recalled five lots of a diabetes drug that were manufactured under a contract by Durham-based Patheon (NYSE: PTHN).
According to Patheon, a problem with the diabetes drug Glipizide arose after the size of the pill bottle was increased, and a drying agent was included in the new bottle.
“The issue was not related to the manufacturing or packaging services provided by Patheon,”…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Jason deBruyn Source Type: news
More News: Allergy | Contracts | Diabetes | Endocrinology | Glipizide | Health | Health Management | Pharmaceuticals